Sarissa Capital Management LP

Q4 2024 13F Holdings

  • Location
    greenwich, CT
  • Num holdings

    8

  • Value ($000)

    $322,863

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001577524
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
INVA
INVA

INNOVIVA INC

COM
45781M101
$126.26M
39 %

7,277,000

IRWD
IRWD

IRONWOOD PHARMACEUTICALS INC

COM CL A
46333X108
$72.61M
23 %

16,390,000

NBIX
NBIX

NEUROCRINE BIOSCIENCES INC

COM
64125C109
$42.19M
13 %

309,116

CYTK
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$39.22M
12 %

833,799

GILD
GILD

GILEAD SCIENCES INC

COM
375558103
$24.21M
8 %

262,080

EH3A
EH3A

AMARIN CORP PLC

SPONS ADR NEW
023111206
$12.05M
4 %

24,850,623

LNTH
LNTH

LANTHEUS HLDGS INC

COM
516544103
$5.64M
2 %

63,000

VOR
VOR

VOR BIOPHARMA INC

COM
929033108
$685.98K
0 %

618,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 8 of 8